サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1220930

関節リウマチ治療薬の世界市場：新たなバイオ医薬品の研究拡大と政府による薬価改定の進展が、市場全体を押し上げる

Growing Research in Novel Biologics and Rising Government Reimbursement on Drug Pricing will Propel the Overall Market for Rheumatoid Arthritis Treatment
出版日: | 発行: Persistence Market Research | ページ情報: 英文 295 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
関節リウマチ治療薬の世界市場：新たなバイオ医薬品の研究拡大と政府による薬価改定の進展が、市場全体を押し上げる
出版日: 2022年12月21日
発行: Persistence Market Research
ページ情報: 英文 295 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の関節リウマチ治療薬市場を調査し、市場の概要や動向、成功要因、市場の背景、セグメント別・地域別の市場分析と予測、競合情勢などをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類法
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 市場のイノベーション/開発動向

第4章 主な成功要因

  • 治療導入分析
  • 患者の治療制度
  • 主な規制
  • PESTEL分析
  • 主なプロモーション戦略：主要企業別

第5章 市場の背景

  • マクロ経済要因
    • 世界のGDP成長の見通し
    • 世界のヘルスケアの見通し
  • 予測要因 - 関連性と影響
    • 研究開発費の増加
    • 生活習慣病の有病率の増加
    • 治療費
    • 戦略的コラボレーション
    • 規制方針の変更
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会分析

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 治療法別
    • 流通チャネル別
    • 国別
  • 2022年の市場シナリオ

第7章 世界の関節リウマチ治療薬市場の需要（金額または規模）の分析と予測

  • 過去の市場分析
  • 現在および将来の市場予測
    • 前年比成長動向分析

第8章 世界の関節リウマチ治療薬市場の分析と予測：治療法別

  • イントロダクション/主な調査結果
  • 過去の市場分析：治療法別
  • 現在および将来の市場分析と予測：治療法別
    • 対症療法
    • 中間コルチコステロイド療法
    • 幹細胞療法
    • 疾患修飾性抗リウマチ薬（DMARD）
  • 市場の魅力度分析：治療法別

第9章 世界の関節リウマチ治療薬市場の分析と予測：流通チャネル別

  • イントロダクション/主な調査結果
  • 過去の市場分析：流通チャネル別
  • 現在および将来の市場分析と予測：流通チャネル別
    • 病院薬局
    • 小売薬局
    • ドラッグストア
  • 市場の魅力度分析：流通チャネル別

第10章 世界の関節リウマチ治療薬市場の分析と予測：地域別

  • イントロダクション
  • 過去の市場分析：地域別
  • 現在および将来の市場分析と予測
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場の魅力度分析：地域別

第11章 北米の関節リウマチ治療薬市場の分析と予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析と予測分析：市場分類別
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場の魅力度分析
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響分析
  • 主要企業 - 強度マッピング
  • 国別の分析と予測
    • 米国の関節リウマチ治療薬市場分析
    • カナダの関節リウマチ治療薬市場分析

第12章 ラテンアメリカの関節リウマチ治療薬市場の分析と予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析と予測分析：市場分類別
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場の魅力度分析
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響分析
  • 主要企業 - 強度マッピング
  • 国別の分析と予測
    • メキシコの関節リウマチ治療薬市場分析
    • ブラジルの関節リウマチ治療薬市場分析
    • アルゼンチンの関節リウマチ治療薬市場分析

第13章 欧州の関節リウマチ治療薬市場の分析と予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析と予測分析：市場分類別
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場の魅力度分析
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響分析
  • 主要企業 - 強度マッピング
  • 国別の分析と予測
    • ドイツの関節リウマチ治療薬市場分析
    • イタリアの関節リウマチ治療薬市場分析
    • フランスの関節リウマチ治療薬市場分析
    • 英国の関節リウマチ治療薬市場分析
    • スペインの関節リウマチ治療薬市場分析
    • ベネルクス諸国の関節リウマチ治療薬市場分析
    • ロシアの関節リウマチ治療薬市場分析

第14章 東アジアの関節リウマチ治療薬市場の分析と予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析と予測分析：市場分類別
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場の魅力度分析
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響分析
  • 主要企業 - 強度マッピング
  • 国別の分析と予測
    • 中国の関節リウマチ治療薬市場分析
    • 日本の関節リウマチ治療薬市場分析
    • 韓国の関節リウマチ治療薬市場分析

第15章 南アジアの関節リウマチ治療薬市場の分析と予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析と予測分析：市場分類別
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場の魅力度分析
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響分析
  • 主要企業 - 強度マッピング
  • 国別の分析と予測
    • インドの関節リウマチ治療薬市場分析
    • インドネシアの関節リウマチ治療薬市場分析
    • マレーシアの関節リウマチ治療薬市場分析
    • タイの関節リウマチ治療薬市場分析

第16章 オセアニアの関節リウマチ治療薬市場と予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析と予測分析：市場分類別
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場の魅力度分析
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響分析
  • 主要企業 - 強度マッピング
  • 国別の分析と予測
    • オーストラリアの関節リウマチ治療薬市場分析
    • ニュージーランドの関節リウマチ治療薬市場分析

第17章 中東・アフリカの関節リウマチ治療薬市場の分析と予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析と予測分析：市場分類別
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場の魅力度分析
    • 国別
    • 治療法別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響分析
  • 主要企業 - 強度マッピング
  • 国別の分析と予測
    • GCC諸国の関節リウマチ治療薬市場分析
    • トルコの関節リウマチ治療薬市場分析
    • 南アフリカの関節リウマチ治療薬市場分析
    • 北アフリカの関節リウマチ治療薬市場分析

第18章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第19章 競合分析

  • 競合ダッシュボード
  • 競合の詳細
    • Sanofi S.A.
    • Pfizer Inc.
    • Johnson & Johnson
    • AbbVie Inc.
    • Eli Lilly & Company
    • Amgen Inc.
    • Bristol-Myers Squibb Company
    • F. Hoffman-La Roche AG
    • Cipla, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Sobi Inc.
    • Novartis AG (Sandoz)
    • UCB S.A..

第20章 前提と使用される頭字語

第21章 調査手法

図表

List of Tables

  • Table 01: Global Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033 By Therapy
  • Table 02: Global Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033By Distribution Channel
  • Table 03: Global Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033 by Region
  • Table 04: North America Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 05: North America Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Therapy
  • Table 06: North America Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Distribution Channel
  • Table 07: Latin America Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 08: Latin America Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Therapy
  • Table 09: Latin America Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Distribution Channel
  • Table 10: Europe Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 11: Europe Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Therapy
  • Table 12: Europe Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033By Distribution Channel
  • Table 13: East Asia Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 14: East Asia Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Therapy
  • Table 15: East Asia Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Distribution Channel
  • Table 16: South Asia Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 17: South Asia Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Therapy
  • Table 18: South Asia Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Distribution Channel
  • Table 19: Oceania Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 20: Oceania Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Therapy
  • Table 21: Oceania Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033By Distribution Channel
  • Table 22: Middle East & Africa Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 by Country
  • Table 23: Middle East & Africa Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033 By Therapy
  • Table 24: Middle East & Africa Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast

List of Figures

  • Figure 01: Global Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022
  • Figure 02: Global Rheumatoid Arthritis Treatment Market Forecast & Y-o-Y Growth 2023-2033
  • Figure 03: Global Rheumatoid Arthritis Treatment Market Absolute $ Opportunity (US$ Mn) Analysis 2022-2033
  • Figure 04: Global Rheumatoid Arthritis Treatment Market Value Share (%) Analysis 2023 and 2033 By Therapy
  • Figure 05: Global Rheumatoid Arthritis Treatment Market Y-o-Y Growth (%) Analysis 2022-2033 By Therapy
  • Figure 06: Global Rheumatoid Arthritis Treatment Market Attractiveness Analysis 2023-2033 By Therapy
  • Figure 07: Global Rheumatoid Arthritis Treatment Market Value Share (%) Analysis 2023 and 2033 By Distribution Channel
  • Figure 08: Global Rheumatoid Arthritis Treatment Market Y-o-Y Growth (%) Analysis 2022-2033 By Distribution Channel
  • Figure 09: Global Rheumatoid Arthritis Treatment Market Attractiveness Analysis 2023-2033 By Distribution Channel
  • Figure 10: Global Rheumatoid Arthritis Treatment Market Value Share (%) Analysis 2023 and 2033 by Region
  • Figure 11: Global Rheumatoid Arthritis Treatment Market Y-o-Y Growth (%) Analysis 2022-2033 by Region
  • Figure 12: Global Rheumatoid Arthritis Treatment Market Attractiveness Analysis 2023-2033 by Region
  • Figure 13: North America Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022
  • Figure 14: North America Rheumatoid Arthritis Treatment Market Value (US$ Mn) Forecast 2023-2033
  • Figure 15: North America Rheumatoid Arthritis Treatment Market Value Share By Therapy (2023 E)
  • Figure 16: North America Rheumatoid Arthritis Treatment Market Value Share By Distribution Channel (2023 E)
  • Figure 17: North America Rheumatoid Arthritis Treatment Market Value Share by Country (2023 E)
  • Figure 18: North America Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Therapy 2023-2033
  • Figure 19: North America Rheumatoid Arthritis Treatment Market Attractiveness Analysis by Country 2023-2033
  • Figure 20: U.S. Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 21: Global Vs. U.S. Growth Comparison 2022 - 2033
  • Figure 22: U.S. Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 23: U.S. Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 24: Canada Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 25: Global Vs. Canada. Growth Comparison 2022 - 2033
  • Figure 26: Canada Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 27: Canada Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 28: Latin America Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022
  • Figure 29: Latin America Rheumatoid Arthritis Treatment Market Value (US$ Mn) Forecast 2023-2033
  • Figure 30: Latin America Rheumatoid Arthritis Treatment Market Value Share By Therapy (2023 E)
  • Figure 31: Latin America Rheumatoid Arthritis Treatment Market Value Share By Distribution Channel (2023 E)
  • Figure 32: Latin America Rheumatoid Arthritis Treatment Market Value Share by Country (2023 E)
  • Figure 33: Latin America Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Therapy 2023-2033
  • Figure 34: Latin America Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Distribution Channel 2023-2033
  • Figure 35: Latin America Rheumatoid Arthritis Treatment Market Attractiveness Analysis by Country 2023-2033
  • Figure 36: Mexico Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 37: Global Vs Mexico Growth Comparison 2022 - 2033
  • Figure 38: Mexico Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 39: Mexico Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 40: Brazil Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 41: Global Vs. Brazil. Growth Comparison 2022 - 2033
  • Figure 42: Brazil Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 43: Brazil Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 44: Argentina Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 45: Global Vs Argentina Growth Comparison 2022 - 2033
  • Figure 46: Argentina Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 47: Argentina Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 48: Europe Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022
  • Figure 49: Europe Rheumatoid Arthritis Treatment Market Value (US$ Mn) Forecast 2023-2033
  • Figure 50: Europe Rheumatoid Arthritis Treatment Market Value Share By Therapy (2023 E)
  • Figure 51: Europe Rheumatoid Arthritis Treatment Market Value Share By Distribution Channel (2023 E)
  • Figure 52: Europe Rheumatoid Arthritis Treatment Market Value Share by Country (2023 E)
  • Figure 53: Europe Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Therapy 2023-2033
  • Figure 54: Europe Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Distribution Channel 2023-2033
  • Figure 55: Europe Rheumatoid Arthritis Treatment Market Attractiveness Analysis by Country 2023-2033
  • Figure 56: UK Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 57: Global Vs. UK Growth Comparison 2022 - 2033
  • Figure 58: UK Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 59: UK Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 60: Germany Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 61: Global Vs. Germany Growth Comparison 2022 - 2033
  • Figure 62: Germany Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 63: Germany Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 64: Italy Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 65: Global Vs. Italy Growth Comparison 2022 - 2033
  • Figure 66: Italy Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 67: Italy Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 68: France Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 69: Global Vs France Growth Comparison 2022 - 2033
  • Figure 70: France Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 71: France Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 72: Spain Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 73: Global Vs Spain Growth Comparison 2022 - 2033
  • Figure 74: Spain Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 75: Spain Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 76: Russia Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 77: Global Vs Russia Growth Comparison 2022 - 2033
  • Figure 78: Russia Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 79: Russia Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 80: BENELUX Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 81: Global Vs BENELUX Growth Comparison 2022 - 2033
  • Figure 82: BENELUX Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 83: BENELUX Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 84: East Asia Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022
  • Figure 85: East Asia Rheumatoid Arthritis Treatment Market Value (US$ Mn) Forecast 2023-2033
  • Figure 86: East Asia Rheumatoid Arthritis Treatment Market Value Share By Therapy (2023 E)
  • Figure 87: East Asia Rheumatoid Arthritis Treatment Market Value Share By Distribution Channel (2023 E)
  • Figure 88: East Asia Rheumatoid Arthritis Treatment Market Value Share by Country (2023 E)
  • Figure 89: East Asia Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Therapy 2023-2033
  • Figure 90: East Asia Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Distribution Channel 2023-2033
  • Figure 91: East Asia Rheumatoid Arthritis Treatment Market Attractiveness Analysis by Country 2023-2033
  • Figure 92: China Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 93: Global Vs. China Growth Comparison 2022 - 2033
  • Figure 94: China Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 95: China Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 96: Japan Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 97: Global Vs. Japan Growth Comparison 2022 - 2033
  • Figure 98: Japan Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 99: Japan Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 100: South Korea Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 101: Global Vs South Korea Growth Comparison 2022 - 2033
  • Figure 102: South Korea Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 103: South Korea Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 104: South Asia Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022
  • Figure 105: South Asia Rheumatoid Arthritis Treatment Market Value (US$ Mn) Forecast 2023-2033
  • Figure 106: South Asia Rheumatoid Arthritis Treatment Market Value Share By Therapy (2023 E)
  • Figure 107: South Asia Rheumatoid Arthritis Treatment Market Value Share By Distribution Channel (2023 E)
  • Figure 108: South Asia Rheumatoid Arthritis Treatment Market Value Share by Country (2023 E)
  • Figure 109: South Asia Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Therapy 2023-2033
  • Figure 110: South Asia Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Distribution Channel 2023-2033
  • Figure 111: South Asia Rheumatoid Arthritis Treatment Market Attractiveness Analysis by Country 2023-2033
  • Figure 112: India Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 113: Global Vs. India Growth Comparison 2022 - 2033
  • Figure 114: India Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 115: India Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 116: Indonesia Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 117: Global Vs. Indonesia Growth Comparison 2022 - 2033
  • Figure 118: Indonesia Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 119: Indonesia Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 120: Malaysia Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 121: Global Vs. Malaysia Growth Comparison 2022 - 2033
  • Figure 122: Malaysia Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 123: Malaysia Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 124: Thailand Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 125: Global Vs. Thailand Growth Comparison 2022 - 2033
  • Figure 126: Thailand Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 127: Thailand Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 128: Oceania Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022
  • Figure 129: Oceania Rheumatoid Arthritis Treatment Market Value (US$ Mn) Forecast 2023-2033
  • Figure 130: Oceania Rheumatoid Arthritis Treatment Market Value Share By Therapy (2023 E)
  • Figure 131: Oceania Rheumatoid Arthritis Treatment Market Value Share By Distribution Channel (2023 E)
  • Figure 132: Oceania Rheumatoid Arthritis Treatment Market Value Share by Country (2023 E)
  • Figure 133: Oceania Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Therapy 2023-2033
  • Figure 134: Oceania Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Distribution Channel 2023-2033
  • Figure 135: Oceania Rheumatoid Arthritis Treatment Market Attractiveness Analysis by Country 2023-2033
  • Figure 136: Australia Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 137: Global Vs. Australia Growth Comparison 2022 - 2033
  • Figure 138: Australia Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 139: Australia Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 140: New Zealand Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 141: Global Vs New Zealand Growth Comparison 2022 - 2033
  • Figure 142: New Zealand Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 143: New Zealand Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 144: Middle East & Africa Rheumatoid Arthritis Treatment Market Value (US$ Mn) Analysis 2016-2022
  • Figure 145: Middle East & Africa Rheumatoid Arthritis Treatment Market Value (US$ Mn) Forecast 2023-2033
  • Figure 146: Middle East & Africa Rheumatoid Arthritis Treatment Market Value Share By Therapy (2023 E)
  • Figure 147: Middle East & Africa Rheumatoid Arthritis Treatment Market Value Share By Distribution Channel (2023 E)
  • Figure 148: Middle East & Africa Rheumatoid Arthritis Treatment Market Value Share by Country (2023 E)
  • Figure 149: Middle East & Africa Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Therapy 2023-2033
  • Figure 150: Middle East & Africa Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Distribution Channel 2023-2033
  • Figure 151: Middle East & Africa Rheumatoid Arthritis Treatment Market Attractiveness Analysis by Country 2023-2033
  • Figure 152: GCC Countries Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 153: Global Vs GCC Countries Growth Comparison 2022 - 2033
  • Figure 154: GCC Countries Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 155: GCC Countries Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 156: Turkey Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 157: Global Vs. Turkey Growth Comparison 2022 - 2033
  • Figure 158: Turkey Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 159: Turkey Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 160: South Africa Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 161: Global Vs. South Africa Growth Comparison 2022 - 2033
  • Figure 162: South Africa Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 163: South Africa Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
  • Figure 164: North Africa Rheumatoid Arthritis Treatment Market Value Proportion Analysis 2022
  • Figure 165: Global Vs North Africa Growth Comparison 2022 - 2033
  • Figure 166: North Africa Rheumatoid Arthritis Treatment Market Share Analysis (%) By Therapy 2022 & 2033
  • Figure 167: North Africa Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel 2022 & 2033
目次
Product Code: PMRREP22555

Rheumatoid Arthritis Treatment Market: Scope of the Report

The latest publication by Persistence Market Research on the global rheumatoid arthritis treatment market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for rheumatoid arthritis treatment and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the rheumatoid arthritis treatment market. Shareholders in the rheumatoid arthritis treatment market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the rheumatoid arthritis treatment market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the rheumatoid arthritis treatment market offers information divided into three important segments - therapy, distribution channel and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Therapy

Symptomatic Treatment

Intermediate Corticosteroid Therapies

Stem Cell Therapy

Disease Modifying Anti-rheumatic Drug (DMARD)

Conventional DMARDs

Biologic DMARDs

Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Drug Stores

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for rheumatoid arthritis treatment over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the rheumatoid arthritis treatment market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the rheumatoid arthritis treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research's projections on the growth prospects of the rheumatoid arthritis treatment market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Therapy Adoption Analysis
  • 4.2. Patient Treatment Regime
  • 4.3. Key Regulations
  • 4.4. PESTEL Analysis
  • 4.5. Key Promotional Strategies, By Key Players

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increase in R&D Spending
    • 5.2.2. Growing Lifestyle Disease Prevalence
    • 5.2.3. Cost of Therapy
    • 5.2.4. Strategic Collaborations
    • 5.2.5. Changes in Regulatory Policies
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Therapy
    • 6.1.2. By Distribution Channel
    • 6.1.3. By Country
  • 6.2. 2022 Market Scenario

7. Global Rheumatoid Arthritis Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2016-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2016-2022
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033, By Therapy

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Therapy, 2016-2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapy, 2023-2033
    • 8.3.1. Symptomatic Treatment
    • 8.3.2. Intermediate Corticosteroid Therapies
    • 8.3.3. Stem Cell Therapy
    • 8.3.4. Disease Modifying Anti-rheumatic Drug (DMARD)
      • 8.3.4.1. Conventional DMARDs
      • 8.3.4.2. Biologic DMARDs
  • 8.4. Market Attractiveness Analysis By Therapy

9. Global Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2016-2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033
    • 9.3.1. Hospital Pharmacy
    • 9.3.2. Retail Pharmacy
    • 9.3.3. Drug Stores
  • 9.4. Market Attractiveness Analysis By Distribution Channel

10. Global Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033, By Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2022
  • 10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Therapy
    • 11.3.3. By Distribution Channel
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Therapy
    • 11.4.3. By Distribution Channel
  • 11.5. Market Trends
  • 11.6. Drivers and Restraints - Impact Analysis
  • 11.7. Key Players - Intensity Mapping
  • 11.8. Country Level Analysis & Forecast
    • 11.8.1. U.S. Rheumatoid Arthritis Treatment Market Analysis
      • 11.8.1.1. Introduction
      • 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.1.2.1. By Therapy
        • 11.8.1.2.2. By Distribution Channel
    • 11.8.2. Canada Rheumatoid Arthritis Treatment Market Analysis
      • 11.8.2.1. Introduction
      • 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.2.2.1. By Therapy
        • 11.8.2.2.2. By Distribution Channel

12. Latin America Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 12.3.1. By Country
      • 12.3.1.1. Mexico
      • 12.3.1.2. Brazil
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Therapy
    • 12.3.3. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Therapy
    • 12.4.3. By Distribution Channel
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Key Players - Intensity Mapping
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. Mexico Rheumatoid Arthritis Treatment Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Therapy
        • 12.8.1.2.2. By Distribution Channel
    • 12.8.2. Brazil Rheumatoid Arthritis Treatment Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Therapy
        • 12.8.2.2.2. By Distribution Channel
    • 12.8.3. Argentina Rheumatoid Arthritis Treatment Market Analysis
      • 12.8.3.1. Introduction
      • 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.3.2.1. By Therapy
        • 12.8.3.2.2. By Distribution Channel

13. Europe Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. Italy
      • 13.3.1.3. France
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. BENELUX
      • 13.3.1.7. Russia
      • 13.3.1.8. Rest of Europe
    • 13.3.2. By Therapy
    • 13.3.3. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Therapy
    • 13.4.3. By Distribution Channel
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Players - Intensity Mapping
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Germany Rheumatoid Arthritis Treatment Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Therapy
        • 13.8.1.2.2. By Distribution Channel
    • 13.8.2. Italy Rheumatoid Arthritis Treatment Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Therapy
        • 13.8.2.2.2. By Distribution Channel
    • 13.8.3. France Rheumatoid Arthritis Treatment Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Therapy
        • 13.8.3.2.2. By Distribution Channel
    • 13.8.4. U.K. Rheumatoid Arthritis Treatment Market Analysis
      • 13.8.4.1. Introduction
      • 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.4.2.1. By Therapy
        • 13.8.4.2.2. By Distribution Channel
    • 13.8.5. Spain Rheumatoid Arthritis Treatment Market Analysis
      • 13.8.5.1. Introduction
      • 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.5.2.1. By Therapy
        • 13.8.5.2.2. By Distribution Channel
    • 13.8.6. BENELUX Rheumatoid Arthritis Treatment Market Analysis
      • 13.8.6.1. Introduction
      • 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.6.2.1. By Therapy
        • 13.8.6.2.2. By Distribution Channel
    • 13.8.7. Russia Rheumatoid Arthritis Treatment Market Analysis
      • 13.8.7.1. Introduction
      • 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.7.2.1. By Therapy
        • 13.8.7.2.2. By Distribution Channel

14. East Asia Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Therapy
    • 14.3.3. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Therapy
    • 14.4.3. By Distribution Channel
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. China Rheumatoid Arthritis Treatment Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Therapy
        • 14.8.1.2.2. By Distribution Channel
    • 14.8.2. Japan Rheumatoid Arthritis Treatment Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Therapy
        • 14.8.2.2.2. By Distribution Channel
    • 14.8.3. South Korea Rheumatoid Arthritis Treatment Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Therapy
        • 14.8.3.2.2. By Distribution Channel

15. South Asia Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Malaysia
      • 15.3.1.4. Thailand
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Therapy
    • 15.3.3. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Therapy
    • 15.4.3. By Distribution Channel
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Rheumatoid Arthritis Treatment Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Therapy
        • 15.8.1.2.2. By Distribution Channel
    • 15.8.2. Indonesia Rheumatoid Arthritis Treatment Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Therapy
        • 15.8.2.2.2. By Distribution Channel
    • 15.8.3. Malaysia Rheumatoid Arthritis Treatment Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Therapy
        • 15.8.3.2.2. By Distribution Channel
    • 15.8.4. Thailand Rheumatoid Arthritis Treatment Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Therapy
        • 15.8.4.2.2. By Distribution Channel

16. Oceania Rheumatoid Arthritis Treatment Market 2016-2023 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Therapy
    • 16.3.1. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Therapy
    • 16.4.3. By Distribution Channel
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Australia Rheumatoid Arthritis Treatment Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Therapy
        • 16.8.1.2.2. By Distribution Channel
    • 16.8.2. New Zealand Rheumatoid Arthritis Treatment Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Therapy
        • 16.8.2.2.2. By Distribution Channel

17. Middle East and Africa (MEA) Rheumatoid Arthritis Treatment Market Analysis 2016-2022 and Forecast 2023-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
  • 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkey
      • 17.3.1.3. North Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Therapy
    • 17.3.3. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Therapy
    • 17.4.3. By Distribution Channel
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. GCC Countries Rheumatoid Arthritis Treatment Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Therapy
        • 17.8.1.2.2. By Distribution Channel
    • 17.8.2. Turkey Rheumatoid Arthritis Treatment Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Therapy
        • 17.8.2.2.2. By Distribution Channel
    • 17.8.3. South Africa Rheumatoid Arthritis Treatment Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Therapy
        • 17.8.3.2.2. By Distribution Channel
    • 17.8.4. North Africa Rheumatoid Arthritis Treatment Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Therapy
        • 17.8.4.2.2. By Distribution Channel

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Deep Dive
    • 19.2.1. Sanofi S.A.
      • 19.2.1.1. Overview
      • 19.2.1.2. Product Portfolio
      • 19.2.1.3. Sales Footprint
      • 19.2.1.4. Key Financials
      • 19.2.1.5. SWOT Analysis
      • 19.2.1.6. Strategy Overview
        • 19.2.1.6.1. Marketing Strategy
        • 19.2.1.6.2. Channel Strategy
    • 19.2.2. Pfizer Inc.
      • 19.2.2.1. Overview
      • 19.2.2.2. Product Portfolio
      • 19.2.2.3. Sales Footprint
      • 19.2.2.4. Key Financials
      • 19.2.2.5. SWOT Analysis
      • 19.2.2.6. Strategy Overview
        • 19.2.2.6.1. Marketing Strategy
        • 19.2.2.6.2. Channel Strategy
    • 19.2.3. Johnson & Johnson
      • 19.2.3.1. Overview
      • 19.2.3.2. Product Portfolio
      • 19.2.3.3. Sales Footprint
      • 19.2.3.4. Key Financials
      • 19.2.3.5. SWOT Analysis
      • 19.2.3.6. Strategy Overview
        • 19.2.3.6.1. Marketing Strategy
        • 19.2.3.6.2. Channel Strategy
    • 19.2.4. AbbVie Inc.
      • 19.2.4.1. Overview
      • 19.2.4.2. Product Portfolio
      • 19.2.4.3. Sales Footprint
      • 19.2.4.4. Key Financials
      • 19.2.4.5. SWOT Analysis
      • 19.2.4.6. Strategy Overview
        • 19.2.4.6.1. Marketing Strategy
        • 19.2.4.6.2. Channel Strategy
    • 19.2.5. Eli Lilly & Company
      • 19.2.5.1. Overview
      • 19.2.5.2. Product Portfolio
      • 19.2.5.3. Sales Footprint
      • 19.2.5.4. Key Financials
      • 19.2.5.5. SWOT Analysis
      • 19.2.5.6. Strategy Overview
        • 19.2.5.6.1. Marketing Strategy
        • 19.2.5.6.2. Channel Strategy
    • 19.2.6. Amgen Inc.
      • 19.2.6.1. Overview
      • 19.2.6.2. Product Portfolio
      • 19.2.6.3. Sales Footprint
      • 19.2.6.4. Key Financials
      • 19.2.6.5. SWOT Analysis
      • 19.2.6.6. Strategy Overview
        • 19.2.6.6.1. Marketing Strategy
        • 19.2.6.6.2. Channel Strategy
    • 19.2.7. Bristol-Myers Squibb Company
      • 19.2.7.1. Overview
      • 19.2.7.2. Product Portfolio
      • 19.2.7.3. Sales Footprint
      • 19.2.7.4. Key Financials
      • 19.2.7.5. SWOT Analysis
      • 19.2.7.6. Strategy Overview
        • 19.2.7.6.1. Marketing Strategy
        • 19.2.7.6.2. Channel Strategy
    • 19.2.8. F. Hoffman-La Roche AG
      • 19.2.8.1. Overview
      • 19.2.8.2. Product Portfolio
      • 19.2.8.3. Sales Footprint
      • 19.2.8.4. Key Financials
      • 19.2.8.5. SWOT Analysis
      • 19.2.8.6. Strategy Overview
        • 19.2.8.6.1. Marketing Strategy
        • 19.2.8.6.2. Channel Strategy
    • 19.2.9. Cipla, Inc.
      • 19.2.9.1. Overview
      • 19.2.9.2. Product Portfolio
      • 19.2.9.3. Sales Footprint
      • 19.2.9.4. Key Financials
      • 19.2.9.5. SWOT Analysis
      • 19.2.9.6. Strategy Overview
        • 19.2.9.6.1. Marketing Strategy
        • 19.2.9.6.2. Channel Strategy
    • 19.2.10. Sun Pharmaceutical Industries Ltd.
      • 19.2.10.1. Overview
      • 19.2.10.2. Product Portfolio
      • 19.2.10.3. Sales Footprint
      • 19.2.10.4. Key Financials
      • 19.2.10.5. SWOT Analysis
      • 19.2.10.6. Strategy Overview
        • 19.2.10.6.1. Marketing Strategy
        • 19.2.10.6.2. Channel Strategy
    • 19.2.11. Sobi Inc.
      • 19.2.11.1. Overview
      • 19.2.11.2. Product Portfolio
      • 19.2.11.3. Sales Footprint
      • 19.2.11.4. Key Financials
      • 19.2.11.5. SWOT Analysis
      • 19.2.11.6. Strategy Overview
        • 19.2.11.6.1. Marketing Strategy
        • 19.2.11.6.2. Channel Strategy
    • 19.2.12. Novartis AG ( Sandoz)
      • 19.2.12.1. Overview
      • 19.2.12.2. Product Portfolio
      • 19.2.12.3. Sales Footprint
      • 19.2.12.4. Key Financials
      • 19.2.12.5. SWOT Analysis
      • 19.2.12.6. Strategy Overview
        • 19.2.12.6.1. Marketing Strategy
        • 19.2.12.6.2. Channel Strategy
    • 19.2.13. UCB S.A..
      • 19.2.13.1. Overview
      • 19.2.13.2. Product Portfolio
      • 19.2.13.3. Sales Footprint
      • 19.2.13.4. Key Financials
      • 19.2.13.5. SWOT Analysis
      • 19.2.13.6. Strategy Overview
        • 19.2.13.6.1. Marketing Strategy
        • 19.2.13.6.2. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology